TEVA PHARMACEUTICAL INDUSTRIES LTD 881624209 US8816242098 05/28/2026 To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers (NEOs). SECTION 14A SAY-ON-PAY VOTES ISSUER 20038010 0 FOR 20038010 FOR 1 TEVA PHARMACEUTICAL INDUSTRIES LTD 881624209 US8816242098 05/28/2026 To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers (NEOs). SECTION 14A SAY-ON-PAY VOTES ISSUER 34945556 0 FOR 34945556 FOR 2 TEVA PHARMACEUTICAL INDUSTRIES LTD 881624209 US8816242098 05/28/2026 To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers (NEOs). SECTION 14A SAY-ON-PAY VOTES ISSUER 5710554 0 FOR 5710554 FOR 3 Ormat Technologies, Inc 686688102 US6866881021 02/06/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 949543 0 FOR 949543 FOR 1 Ormat Technologies, Inc 686688102 US6866881021 02/06/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1640887 0 FOR 1640887 FOR 2 Ormat Technologies, Inc 686688102 US6866881021 02/06/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 819874 0 FOR 819874 FOR 3 Palo Alto Networks, Inc. 697435105 US6974351057 09/12/2025 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 43769 0 AGAINST 43769 AGAINST 1 Palo Alto Networks, Inc. 697435105 US6974351057 09/12/2025 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 66229 0 AGAINST 66229 AGAINST 2 UroGen Pharma Ltd M96088105 IL0011407140 06/22/2026 To approve an amendment to the Company’s Amended and Restated Non-Employee Director and Officer Compensation Policy in relation to directors’ and officers’ insurance. SECTION 14A SAY-ON-PAY VOTES ISSUER 276528 0 AGAINST 276528 AGAINST 1 UroGen Pharma Ltd M96088105 IL0011407140 06/22/2026 To approve an amendment to the Company’s Amended and Restated Non-Employee Director and Officer Compensation Policy in relation to directors’ and officers’ insurance. SECTION 14A SAY-ON-PAY VOTES ISSUER 494380 0 AGAINST 494380 AGAINST 2 UroGen Pharma Ltd M96088105 IL0011407140 06/22/2026 To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 276528 0 AGAINST 276528 AGAINST 1 UroGen Pharma Ltd M96088105 IL0011407140 06/22/2026 To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 494380 0 AGAINST 494380 AGAINST 2